• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » depressive_disorder

Articles Tagged with ''depressive_disorder''

Rexulti for Schizophrenia and MDD: Is It Abilify, Round 2?

September 1, 2015
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
On July 10, the U.S. Food and Drug Administration (FDA) approved Otsuka and Lundbeck’s Rexulti (brexpiprazole) for schizophrenia and as an add-on to antidepressants for adults with depression. As the name suggests, it’s chemically and structurally related to aripiprazole (Abilify).
Read More

Neurostimulation Devices for Depression: An Overview

July 1, 2015
James Recht, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
James Recht, MD Psychiatrist based in Cambridge, MA Dr. Recht has disclosed that he had no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
When we last reviewed neurostimulation devices 3 years ago, we concluded that there was some promise—but more sizzle than beef. Now there are more devices and more data. But is there more beef? Maybe.
Read More

Fisher Wallace and Alpha-Stim for Depression? Claims vs Evidence

July 1, 2015
Gregory L. Sahlem, MD and Jeffrey J. Borckardt, PhD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Gregory L. Sahlem, MD Clinical instructor of Psychiatry and Behavioral Sciences, Medical University of South Carolina Dr. Sahlem has disclosed that the has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.   Jeffrey J. Borckardt, PhD Associate Professor and Director of the Biobehavioral Medicine Division, Brain Stimulation Laboratory and Biobehavioral Medicine Division, Medical University of South Carolina Dr. Borckhardt has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
Carly Simon swears by it. The daytime show “The Doctors” gave it a glowing review. Ads for it seem to be invading psychiatrists’ Google search results. We’re talking, of course, about the Fisher Wallace Stimulator and the similarly touted Alpha-Stim device. How do these devices work? Are they actually effective? And where do they fit into the rapidly expanding array of neuromodulators?
Read More

Which TMS Device Should You Buy?

July 1, 2015
Daniel Carlat, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Daniel Carlat, MD Editor-in-Chief, Publisher, The Carlat Report. Dr. Carlat has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
So let’s say you’ve decided to take the TMS plunge. With three devices currently FDA cleared, you have some decisions to make. The following table brings together some information you might find useful focusing on the Neronetics and Brainsway devices.
Read More

Reflections on the Past and Future of TMS

July 1, 2015
Mark George, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Mark George, MD Distinguished University Professor, Layton McCurdy Endowed Chair, Director, Brain Stimulation Laboratory Dr. George discloses that he is an unpaid consultant to Brainsonix, Brainsway, Cerval/Neostim, Mecta, Neuronetics, NeoSync, Nervive, and Puretech Ventures. Dr. Carlat has reviewed this interview and found no evidence of bias in this educational activity.
Mark George, MD started working on transcranial magnetic stimulation in 1993. In this interview he discusses the history of TMS and the state of trials and treatment options for patients 20 years later.
Read More

The Practice of Interventional Psychiatry

July 1, 2015
Nolan Williams, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Nolan Williams, MD Instructor, Psychiatry and Behavioral Sciences, Stanford University Dr. Williams has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Dr. Williams discusses the field of interventional psychiatry from a practical standpoint by outlining the philosophy, practice, and case studies where interventional strategies have been effective.
Read More

To Prevent Depression in Teens, Teach About Change

November 1, 2014
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Transitioning to high school can be a tough time, and studies have shown that teenagers are increasingly likely to have symptoms of depression over the course of their freshman year of school. Now an intriguing study seems to show that a simple intervention can ease these symptoms quite effectively.
Read More

NSAIDs May be Effective for Depression

November 1, 2014
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Inflammation is hot, both literally and figuratively. The medical literature is replete with studies implicating inflammation as a possible root cause of diseases as varied as heart disease, cancer, Alzheimer’s disease, depression and, of course, arthritis. A recent meta-analysis of all randomized controlled studies for depression yielded some intriguing results.
Read More

Family Therapy for Serious Illness and Death

July 10, 2014
Jay Coburn, MA, MS
...
Read More

Recognizing and Treating Complicated Grief

July 10, 2014
Nicole J. LeBlanc, BS
It is widely recognized that the death of a loved one commonly triggers intense sorrow and emotional pain. However, scientists have long known that there is more to grief than just sadness.Bereaved individuals can experience a range of emotions, cognitions, and behaviors following loss. Typical grief reactions can range from...
Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2603816031.jpg
    General Psychiatry

    A Scam for Every Woman, Child, and Man: Part 2

    1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.